VCS
Vaughan & Co Securities’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $649K | Sell |
26,792
-74
| -0.3% | -$1.79K | 0.37% | 32 |
|
2025
Q1 | $681K | Hold |
26,866
| – | – | 0.42% | 33 |
|
2024
Q4 | $713K | Sell |
26,866
-289
| -1% | -$7.67K | 0.43% | 31 |
|
2024
Q3 | $786K | Sell |
27,155
-415
| -2% | -$12K | 0.46% | 28 |
|
2024
Q2 | $771K | Buy |
27,570
+8,370
| +44% | +$234K | 0.49% | 21 |
|
2024
Q1 | $533K | Sell |
19,200
-1,718
| -8% | -$47.7K | 0.34% | 44 |
|
2023
Q4 | $602K | Buy |
20,918
+8,480
| +68% | +$244K | 0.4% | 41 |
|
2023
Q3 | $413K | Hold |
12,438
| – | – | 0.31% | 46 |
|
2023
Q2 | $456K | Hold |
12,438
| – | – | 0.32% | 47 |
|
2023
Q1 | $507K | Buy |
12,438
+381
| +3% | +$15.5K | 0.38% | 46 |
|
2022
Q4 | $618K | Sell |
12,057
-298
| -2% | -$15.3K | 0.49% | 36 |
|
2022
Q3 | $541K | Sell |
12,355
-48
| -0.4% | -$2.1K | 0.47% | 37 |
|
2022
Q2 | $650K | Hold |
12,403
| – | – | 0.52% | 32 |
|
2022
Q1 | $642K | Sell |
12,403
-446
| -3% | -$23.1K | 0.44% | 38 |
|
2021
Q4 | $759K | Sell |
12,849
-336
| -3% | -$19.8K | 0.51% | 23 |
|
2021
Q3 | $567K | Sell |
13,185
-211
| -2% | -$9.07K | 0.42% | 37 |
|
2021
Q2 | $525K | Hold |
13,396
| – | – | 0.39% | 38 |
|
2021
Q1 | $485K | Hold |
13,396
| – | – | 0.39% | 39 |
|
2020
Q4 | $493K | Sell |
13,396
-331
| -2% | -$12.2K | 0.44% | 26 |
|
2020
Q3 | $504K | Sell |
13,727
-458
| -3% | -$16.8K | 0.53% | 22 |
|
2020
Q2 | $464K | Hold |
14,185
| – | – | 0.51% | 28 |
|
2020
Q1 | $463K | Hold |
14,185
| – | – | 0.59% | 21 |
|
2019
Q4 | $556K | Buy |
+14,185
| New | +$556K | 0.5% | 34 |
|